Matches 1 - 50 out of 144 1 2 3 >
Match Document Document Title
7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds  
Peptide ligands having affinity for IgG or for serum albumin are disclosed. Also disclosed are hybrid molecules comprising a peptide ligand domain and an active domain. The active domain may...
7598093 Nanoparticle and microparticle based detection of cellular products  
Embodiments of the present invention relate to devices and methods for detecting cellular products using detection particles having product-specific detection reagents and having a characteristic...
7592186 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin A complexes in a blood sample  
The present invention provides methods, diagnostic assays, and diagnostic kits based on said methods, to determine levels of immunosuppressive complexes containing immunosuppressive drugs...
7588905 Identification and monitoring of systemic lupus erythematosus  
A method for identifying or monitoring SLE in an individual is provided. The method includes quantitating complement component C4d on the surfaces of platelets and comparing the amounts of C4d to...
7585640 Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells  
The invention is related to methods of diagnosing inflammatory diseases or conditions by determining levels of components of the complement pathway on the surface of white blood cells.
7462495 Methods and compositions for use in diagnosing and characterizing chronic immune disease  
Methods are provided for diagnosing and/or characterizing chronic immune disease activity in a subject. In the subject methods, a sample is obtained from a subject suspected of having or known to...
7410802 Methods for simultaneously detecting both members of a binding pair  
Methods and kits for simultaneously measuring both members of a binding pair are described.
7402403 Tumour markers  
A method of determining the immune response of a mammal to circulating tumour marker proteins is described in which a sample of bodily fluid, for example plasma or serum, is contacted with a panel...
7390631 Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma  
Methods for diagnosing and monitoring systemic lupus erythematosus (SLE) or scleroderma by determining, in a blood sample from the individual being diagnosed or monitored, complement component C4d...
7361480 Method and means for detecting gluten-induced diseases  
The invention is directed to a method of detecting gluten-induced diseases such as e.g. celiac disease and dermatitis herpetiformis. Said diseases are indicated by the presence of autoantibodies...
7361479 Assay  
The present invention provides a method of determining the presence or amount of newly synthesized antibody in a sample in response to an immunogen by detecting the released antibodies or parts...
7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease  
Methods for diagnosis, early diagnosis, differential diagnosis, assessment of the severity and therapy-accompanying monitoring and prognosis of chronically inflammatory intestinal diseases (Crohn's...
7332349 Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays  
Disclosed are methods relating to cell membrane fragments associated with microbeads, so that the characteristics of the cells the fragments originated from can be determined. The fragments can be...
7291473 Screening process for atopic dermatitis  
The present invention provides a process of screening patients for atopic dermatitis. The process includes the step of determining, in sera of the patient, the presence of antibodies against...
7285242 Biochemical analysis unit and biochemical analyzing method using the same  
A biochemical analysis unit includes a substrate made of a material capable of attenuating radiation energy and/or light energy and formed with a plurality of holes, and a plurality of absorptive...
7258994 Saliva immunoassay for detection of antibodies for cardiovascular disease  
A method for diagnosing the likelihood and severity of cardiovascular disease in a patient is disclosed. The method determines the levels of antibodies against autoantigens, including myosin,...
7252961 Competitive immunoassay using complexed analyte derivatives  
The invention relates to a method for the detection of an analyte in a competitive immunoassay in the presence of an analyte derivative and first and second receptor molecules, and to a kit for...
7205382 Peptides, the production and use thereof for binding immunoglobulins  
Peptides having the following amino acid sequence as well as peptides or proteins which contain this amino acid sequence: R 1...
7195881 Method and kit for following neurodegenerative diseases  
The invention relates to a method for detecting and supervising neurodegenerative diseases, which consists in detecting the presence of antibodies of the A-isotype and/or M-isotype which are...
7179612 Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality  
A method for diagnosing a condition of a patient involves the steps of (a) adding one or more reagents to a test sample from a patient, the test samples comprising at least part of a blood sample...
7176035 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction  
The invention relates to protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction. Using overlapping hexapeptides that...
7175989 Antibodies to trisulfated heparin disaccharide in painful sensory axonal neuropathy  
Methods aiding in the diagnosis of certain painful, predominantly sensory, polyneuropathies are disclosed, in which the amount of antibodies to trisulfated disaccharide is assessed in a test...
7157234 Detection of very low quantities of analyte bound to a solid phase  
A microscale binding assay, analyte binding array, and kits are disclosed, which exploit the mass action law to harvest analyte from a liquid sample. This is achieved by fabrication of sorbent...
7122380 Pharmaceutical compositions containing antigen-antibody complexes and uses therefor  
A pharmaceutical composition suitable for administration to human beings in the prevention or treatment of immunologic disorders includes: an immune complex of an antigen and a purified...
7026132 Method of monitoring the effect of Cathepsin S inhibitors  
The present invention relates to a method for monitoring the effect of in vivo administration of Cathepsin S inhibitors by measuring accumulation of an intermediate degradation product of invariant...
6951763 Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups  
Methods of detecting antibodies to one or more glycosphingolipid(s) of interest in a sample are disclosed which comprise using a solid-phase reactant having carbonyl groups attached theron, and the...
6951716 Anti-platelet immunoglobulin bead positive control  
Immunoassay methods and apparatus are provided which utilize flow cytometry, coated latex microspheres, and fluorochrome labeled antibodies, to simultaneously detect the presence and amount of one...
6933106 Platelet immunoglobulin bead suspension and flow cytometry  
Immunoassay methods and apparatus are provided which utilize flow cytometry, coated latex microspheres, and fluorochrome labeled antibodies, to simultaneously detect the presence and amount of one...
6887672 Anti-equine Fc epsilon receptor alpha chain antibodies and methods to detect IgE  
The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and...
6878811 Substance with antithrombotic activity and method for detecting glycokallidin  
A method for conveniently detecting binding between the von Willebrand factor and glycoprotein Ib and a means to be used therein. The von Willebrand factor fixed in a reactor immobilized in a...
6866846 Patient-specific immunoadsorbers for the extracorporeal apheresis and methods for their preparation  
A process for preparing a patient-specific immunoadsorber, which comprises (i) extracting a body fluid from a patient having an immunopathological condition, the fluid containing immune complexes...
6864062 Purified antigen for Alzheimer's disease and methods of obtaining and using same  
The invention relates, among other things, a preparation comprising Alzheimer's disease antigen (A68), as well as methods of obtaining this purified antigen, and methods of using this purified...
6852546 Diagnosis of autoimmune disease  
The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and...
6835382 Ii peptide therapeutics to enhance antigen presentation  
Disclosed is a class of compounds referred to herein as effector compounds. Effector compounds are useful in connection with the modulation of an immune response. Modulation refers to the ability...
6824986 Methods for measuring in vivo cytokine production  
The present invention involves techniques for evaluating in vivo cytokine production through the in vivo capture of secreting cytokines by labeled cytokine-binding reagents, followed by in vitro...
6824975 Incorporation of selective binding substances in a solid phase assay device  
This invention discloses a method and composition for detecting the presence of class specific antibodies reactive with analytes such as bacteria, allergens, autoimmune antigens, viral proteins,...
6815172 Methods and compositions for opsonophagocytic assays  
Methods and compositions comprising immunoassays for the detection of functional antibodies and the analysis of vaccine efficacy are described. In particular, the present invention provides...
6803196 Methods and compositions for detecting signals in binding assays using microparticles  
Methods and compounds are provided for detecting target molecules in a sample using specific binding assays. In particular, methods are provided for detecting a nucleic acid target in a sample. In...
6777193 Methods for diagnostic and/or treatment of antiphospholipids antibodies-related diseases, and devices  
Methods for detecting anti-lipidic particles antibodies and lipidic particles in cellular membranes for the diagnosis of diseases associated to the antiphospholipid syndrome are disclosed. Kits or...
6733980 Diagnostic method for detection of molecular forms of eosinophilic cationic protein (ISO-ECPS)  
Diagnostic methods comprise measuring specifically the level of at least one iso-eosinophilic cationic protein (iso-ECP) in a sample from an individual to be diagnosed, and comparing the measured...
6727072 EGF-r detection kit  
A kit containing the reagents necessary for the qualitative or quantitative demonstration of epidermal growth factor receptor (EGFR) in formalin-fixed, paraffin-embedded tissue sections. A...
6649354 Catalytically generated mass labels  
The present invention involves a method for assaying a substance. The method of the present invention comprises contacting the substance with an assay agent comprising a catalytic agent to...
6635469 Pressure-mediated binding of biomolecular complexes  
The invention relates to ( 1 ) pressure-mediated dissociation of an analyte complexed with an endogenous binding partner to enable detection of a complex formed from the analyte and an exogenous...
6627458 Nuclear envelope protein recognized by atypical p-ANCA in patients with inflammatory bowel disease and autoimmune liver diseases  
The present invention is directed to the molecular characterization of the nuclear antigen recognized by atypical p-antineutrophil cytoplasmic antibodies (p-ANCA) in order to better diagnose...
6558961 Immunodiagnostics using particle delivery methods  
Methods for assessing immunocompetence, cellular or humoral immunity, antigen exposure, or allergic conditions in an individual by accelerating diagnostic particles into a target skin site in the...
6514714 Method for immunobead flow cytometric detection of anti-HLA panel reactive antibody  
The present invention provides an improved method for detection of panel reactive antibodies in serum of a subject against HLA class I antigens, which comprises the steps of adding serum from a...
6489129 Antigen-specific IgM detection  
The invention concerns a method for the determination of antigen-specific antibodies of the immunoglobulin M class in the presence of immunoglobulins of the G class and/or rheumatoid factors in...
6455244 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents  
This invention is directed toward methods and kits for the detection of antibodies associated with autoimmune disorders or infectious agents in an individual employing immunoretroid peptides...
6429024 Test method for IgA nephropathy  
A test method for IgA nephropathy involves determining antibody, which recognizes the core peptide of the hinge region in IgA1, in specimens. The method is a rapid and sample test method for IgA...
6416955 Eosinophil degranulating conditions  
The invention provides methods and materials related to the diagnosis of eosinophil degranulating conditions. Specifically, the invention provides methods and materials that involve visual types of...
Matches 1 - 50 out of 144 1 2 3 >